Tildrakizumab Real-World Experience (T-REX) in Plaque Psoriasis: Meta-Analysis of Four Non-interventional Studies
Tildrakizumab showed consistent effectiveness across different study populations. Substantial effectiveness was achieved over 28 weeks. Safety results were comparable across populations, without outliers in older patients or patients with higher disease burden. Graphical abstract available for this article.
Authors
- Nina Magnolo (ORCID: https://orcid.org/0000-0001-6802-0153)
- Frank Andersohn (ORCID: https://orcid.org/0000-0003-3514-9238)
- Afra Kempf
- Georgios Kokolakis
- Astrid Kirsch
- Athanasios Tsianakas
- Dennis Niebel
Institutions
- University Hospital Regensburg (DE)
- Humboldt-Universität zu Berlin (DE)
- DB Engineering & Consulting (Germany) (DE)
- Klinik und Poliklinik für Hautkrankheiten (DE)
- Zentralklinik Bad Berka (DE)
- Almirall (Germany) (DE)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2026-03-28
- DOI
- https://doi.org/10.1007/s13555-026-01713-1
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00